616466 InhibitorSelect™ TGF-βR and BMPR Signaling Pathway Inhibitor Panel

616466
Price could not be retrieved
Minimum Quantity needs to be mulitiple of
Upon Order Completion More Information
You Saved ()
 
Request Pricing
Limited AvailabilityLimited Availability
Stocked 
Discontinued
Limited Quantities Available
Available
    Remaining : Will advise
      Remaining : Will advise
      Will advise
      Contact Customer Service
      Contact Customer Service
      View Pricing & Availability

      Overview

      Replacement Information

      Key Specifications Table

      Pricing & Availability

      Catalog Number AvailabilityPackaging Qty/Pack Price Quantity
      616466-1EA
      Retrieving availability...
      Limited AvailabilityLimited Availability
      Stocked 
      Discontinued
      Limited Quantities Available
      Available
        Remaining : Will advise
          Remaining : Will advise
          Will advise
          Contact Customer Service
          Contact Customer Service

          Glass bottle 1 ea
          Retrieving price...
          Price could not be retrieved
          Minimum Quantity needs to be mulitiple of
          Upon Order Completion More Information
          You Saved ()
           
          Request Pricing
          Description
          OverviewA panel containing 18 potent, selective and cell-permeable inhibitors that are useful for the study of TGF-βR and BMPR signaling pathway: 2 mg of Akt Inhibitor XIII, Isozyme-Selective, Akti2-1/2 (Cat. No. 124030), 1 mg of Dorsomorphin (AMPK Inhibitor, Compound C; Cat. No. 171260), 5 mg of ET-18-OCH3 (Cat. No. 341207), 5 mg of IRAK-1/4 Inhibitor (Cat. No. 407601), 500 µg of JAK Inhibitor I, Pyridone 6 (Cat. No. 420099), 5 mg of MG-132 (Cat. No. 474790), 1 mg of (5Z)-7-Oxozeaenol, Curvularia sp. (Cat. No. 499610), 5 mg of p21-Activated Kinase Inhibitor III, IPA-3 (Cat. No. 506106), 1 mg of PD 169316 (Cat. No. 513030), 1 mg of PI-103 (Cat. No. 528100), 5 mg of Rac1 Inhibitor (Cat. No. 553502), 500 µg of Ro-31-8220 (Cat. No. 557520), 1 mg of Smad3 Inhibitor, SIS3 (Cat. No. 566405), 10 mg of STAT3 Inhibitor III, WP1066 (Cat. No. 573097), 1 mg of TGF-β RI Kinase Inhibitor II (Cat. No. 616452), 5 mg of TGF-β RI Kinase Inhibitor VI, SB431542 (Cat. No. 616461), 1 mg of U0126 (Cat. No. 662005), 1 mg of Y-27632 (Cat. No. 688000). Also provided with 15 ml of anhydrous DMSO (Cat. No. KP31817). Supplied with a data sheet.
          Catalogue Number616466
          Brand Family Calbiochem®
          Application Data

          References
          ReferencesPardali, E., et al. 2010. Trends Cell Biol. 20, 556.
          Mosse, Y.P., et al. 2009. Clin. Cancer Res. 15, 5609.
          Clarke, D.C. and Liu, X., 2008 Trends Cell Biol. 18, 430.
          Product Information
          FormSolid
          Hygroscopic Hygroscopic
          Applications
          Biological Information
          Physicochemical Information
          Dimensions
          Materials Information
          Toxicological Information
          Safety Information according to GHS
          Safety Information
          Product Usage Statements
          Storage and Shipping Information
          Ship Code Shipped with Blue Ice or with Dry Ice
          Toxicity Regulatory Review
          Storage -20°C
          Protect from Light Protect from light
          Hygroscopic Hygroscopic
          Do not freeze Ok to freeze
          Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C) each inhibitor. Each inhibitor solution is stable for up to 3 months at -20°C.
          Packaging Information
          Packaged under inert gas Packaged under inert gas
          Transport Information
          Supplemental Information
          Specifications

          Documentation

          InhibitorSelect™ TGF-βR and BMPR Signaling Pathway Inhibitor Panel Certificates of Analysis

          TitleLot Number
          616466

          References

          Reference overview
          Pardali, E., et al. 2010. Trends Cell Biol. 20, 556.
          Mosse, Y.P., et al. 2009. Clin. Cancer Res. 15, 5609.
          Clarke, D.C. and Liu, X., 2008 Trends Cell Biol. 18, 430.
          Data Sheet

          Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

          Revision21-July-2011 RFH
          Application Data

          DescriptionA panel containing 18 potent, selective and cell-permeable inhibitors that is useful for the study of TGF-βR and BMPR signaling pathway. This panel contains the following inhibitors as well as 15 ml anhydrous DMSO for reconstitution:
          FormSolid
          Intert gas (Yes/No) Packaged under inert gas
          SolubilityDMSO (supplied). Please refer to information provided on the CD for reconstitution information of individual inhibitors.
          Storage -20°C
          Hygroscopic
          Protect from light
          Do Not Freeze Ok to freeze
          Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C) each inhibitor. Each inhibitor solution is stable for up to 3 months at -20°C.
          Toxicity Regulatory Review
          ReferencesPardali, E., et al. 2010. Trends Cell Biol. 20, 556.
          Mosse, Y.P., et al. 2009. Clin. Cancer Res. 15, 5609.
          Clarke, D.C. and Liu, X., 2008 Trends Cell Biol. 18, 430.